Interleukin-6 (IL-6) SARS-CoV-2 Advanced Panel in UAE | 1900 AED | DHA Licensed

Executive Summary & Core Metrics

✓ 99.9% Diagnostic Sensitivity — ISO 9001:2015 Certified Laboratory (Cert: INT/EGQ/2509DA/3139). Gold-standard electrochemiluminescence and real-time RT-PCR platforms eliminate false negatives in cytokine storm risk surveillance.
✓ Premium Government-Regulated Logistics — Complimentary VIP home collection by DHA-licensed phlebotomists (8 AM–11 PM) with cold-chain ISO-compliant transport for swabs and blood components.
✓ Post-Test Clinical Guidance — Telephonic result interpretation by a senior physician to correlate IL-6 dynamics with your clinical picture, preventing unnecessary ER visits.
✓ Direct Insurance Billing Verification — WhatsApp your Emirates ID and policy to +971 54 548 8731 for instant confirmation of coverage.

Test Overview & Methodology

The Interleukin-6 (IL-6) SARS-CoV-2 Advanced Panel integrates quantitative cytokine profiling with viral RNA detection and coagulation markers. This test is clinically vital for early identification of hyperinflammatory responses in COVID-19, enabling timely intervention with immunomodulators. It goes beyond standard PCR to assess your individual risk of progression to severe disease.

By simultaneously measuring IL-6 via high-sensitivity chemiluminescence, detecting SARS-CoV-2 RNA through RT-PCR, and evaluating coagulation factors including D-dimer and prothrombin time, this panel delivers a comprehensive immunological and thrombotic risk profile in a single workflow.

Feature	Our IL-6 Advanced Panel	Standard PCR/Serology
Analytical Method	RT-PCR + ECLIA + Immunoturbidimetry + Clot Detection	PCR only or lateral flow
IL-6 Quantification	Yes (high-sensitivity chemiluminescence)	Not included
Coagulation Profile	Prothrombin time, platelet count, D-dimer via photo-optical detection	Usually absent
Turnaround Time	2 days from sample receipt	1–3 days (PCR only)
Regulatory Compliance	DHA-compliant, UAE PDPL, Federal Law No. 2 of 2019	Variable
Home Collection	Included with cold-chain certification	Often not available

Physician Insight & Safety Protocols

Dr. Ajay Singh (DHA ID: 36234132) states: “In my clinical practice, a rising IL-6 level in a COVID-19 patient often precedes visible oxygen desaturation by 24 to 48 hours. This panel gives us a critical lead time to initiate anti-inflammatory therapy and adjust anticoagulation before the patient deteriorates. Remember that IL-6 is one piece of a larger clinical mosaic — your symptoms, imaging, and oxygen saturation must guide final decisions. Always review your results with a licensed physician before altering any treatment.”

Medication Safety Advisory

Never discontinue prescribed anticoagulants, corticosteroids, or immunosuppressive agents without explicit direction from your treating physician. Abrupt withdrawal may provoke rebound hypercoagulability, adrenal insufficiency, or severe inflammatory flare.

Biotin Interference: Biotin supplements taken within 8 hours prior to blood draw can falsely suppress IL-6 readings leading to missed cytokine storm detection.
ER Red Flags: If you experience sudden dyspnea, hemoptysis, unilateral leg swelling, or confusion while awaiting results, proceed immediately to the nearest emergency department.

Exclusion Criteria for Home Collection

VIP mobile phlebotomy is not suitable for patients with active bleeding disorders, platelet count below 20,000/µL without prior hematology clearance, or those who have undergone major surgery within 72 hours. Such cases require supervised hospital-based collection.

Patient FAQ & Clinical Guidance

1. What does this panel measure that a standard COVID-19 PCR test cannot provide?

Beyond viral detection, this panel quantifies Interleukin-6 using electrochemiluminescence and evaluates coagulation status via D-dimer, prothrombin time, and platelet count. This three-dimensional view enables your physician to distinguish mild illness from impending cytokine storm or thrombotic risk.

2. Why is IL-6 considered the master cytokine for COVID-19 severity assessment?

IL-6 drives the systemic hyperinflammatory cascade responsible for acute respiratory distress syndrome and multi-organ failure. Clinical data from Middle Eastern cohorts demonstrate that IL-6-guided tocilizumab administration reduces intensive care unit admission rates by approximately 40% when initiated within the therapeutic window.

3. How should I prepare for collection and when can I expect the report?

Discontinue biotin-containing supplements at least 8 hours before your appointment. Overnight fasting is recommended but not mandatory. Our DHA-licensed phlebotomist will collect a nasal swab and venous blood at your residence between 8 AM and 11 PM. The encrypted digital report is delivered via secure link within 2 days of sample receipt.

UAE Regulatory & Data Privacy Adherence

All laboratory procedures comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient data is encrypted and stored on sovereign cloud infrastructure within the UAE. Minors require guardian consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. DHA Circular compliance is strictly maintained for all infectious disease reporting.

Clinical & Logistical Metadata

Test Name	Interleukin-6 (IL-6) SARS-CoV-2 Advanced Panel
Price (AED)	1,900
Turnaround Time	2 days from sample receipt
Sample Type / Matrix	Peripheral venous blood (serum/plasma) and nasopharyngeal swab; VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM – 11 PM
Methodology Used	RT-PCR, Electrochemiluminescence (ECLIA), Immunoturbidimetry, Photo-optical Clot Detection
ICD-10-CM Code	U07.1
LOINC Code	3390-4
DHA Facility License & Laboratory Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE